Evidence map›Paper›PMID 21474539›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2011

Identification of MIG12 as a mediator for stimulation of lipogenesis by LXR activation.

Jun Inoue, Kohei Yamasaki, Emina Ikeuchi, Shin-ichi Satoh, Yoko Fujiwara, Tomoko Nishimaki-Mogami, Makoto Shimizu, Ryuichiro Sato

Abstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jun InoueDepartment of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.
Kohei Yamasaki
Emina Ikeuchi
Shin-ichi Satoh
Yoko Fujiwara
Tomoko Nishimaki-Mogami
Makoto Shimizu
Ryuichiro Sato
The University of Tokyo · JPNational Institute of Health Sciences · JPOchanomizu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver X receptor (LXR)α and LXRβ belong to the nuclear receptor superfamily and play central roles in the transcriptional control of lipid metabolism. We describe a novel LXR target, midline-1-interacting G12-like protein (MIG12), which has been recently identified as an acetyl-coenzyme A carboxylase-binding protein. The binding causes the induction of de novo fatty acid (FA) synthesis through the activation of acetyl-coenzyme A carboxylase (a rate-limiting enzyme for de novo FA synthesis). Luciferase reporter gene assays using the MIG12 gene promoter revealed the existence of a LXR-responsive element (LXRE) and carbohydrate-responsive element-binding protein (ChREBP)-responsive element named LXRE3 and carbohydrate response element 1, respectively. Deletion and mutation of LXRE3 and carbohydrate response element 1 abolished LXR and ChREBP responsiveness, respectively. Electrophoretic mobility shift assays demonstrated that the LXRα/retinoid X receptor α complex was bound to LXRE3. Treatment with high glucose concentration, which leads ChREBP activation, or LXR activator stimulated MIG12 expression in rat primary hepatocytes, and combined treatment further stimulated MIG12 expression. Furthermore, hepatic expression of MIG12 in mice was induced by refeeding. Overexpression of MIG12 stimulated and knockdown of MIG12 attenuated LXR ligand-stimulated de novo FA synthesis and triacylglycerol accumulation. These results indicate that MIG12 is a mediator for stimulation of lipogenesis by LXR activation in the liver.

Indexed as

AnimalsAnticholesteremic AgentsBase SequenceBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBenzenesulfonamidesCells, CulturedFatty AcidsFluorocarbonsGene Expression RegulationGenes, ReporterHEK293 CellsHepatocytesHumansHydrocarbons, FluorinatedLipogenesisLiver X ReceptorsAnticholesteremic AgentsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBenzenesulfonamidesFatty AcidsFluorocarbonsHydrocarbons, FluorinatedLiver X ReceptorsLuciferasesMicrotubule-Associated ProteinsMig12 protein, mouseMlxipl protein, mouseNR1H3 protein, humanNr1h3 protein, mouseNr1h3 protein, ratNuclear ProteinsOrphan Nuclear ReceptorsSulfonamidesT0901317Transcription FactorsTriglycerides

Identifiers

PMID21474539
PMCPMC5417257
OpenAlexW2051101009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.